Anne Borgman - Oct 12, 2022 Form 4 Insider Report for CURIS INC (CRIS)

Role: Director
Signature: /s/ Diantha Duvall, Attorney-in-fact
Stock symbol: CRIS
Transactions as of: Oct 12, 2022
Transactions value $: $0
Form type: 4
Date filed: 10/14/2022, 04:06 PM
Previous filing: Jun 24, 2022
Next filing: Jan 24, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CRIS	Non Qualified Stock Option	Award	$0	+25K		$0.00	25K	Oct 12, 2022	Common stock	25K	$0.73	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Options granted under the Fourth Amended and Restated 2010 Stock Incentive Plan and will vest over a period of four years with 25% of the shares underlying the stock option vesting on October 12, 2023, and an additional 6.25% of the shares vesting at the end of each successive three-month period thereafter until the options are fully vested on October 12, 2026, subject to Dr. Borgman's continued service on the Company's Board.

Content

Options granted under the Fourth Amended and Restated 2010 Stock Incentive Plan and will vest over a period of four years with 25% of the shares underlying the stock option vesting on October 12, 2023, and an additional 6.25% of the shares vesting at the end of each successive three-month period thereafter until the options are fully vested on October 12, 2026, subject to Dr. Borgman's continued service on the Company's Board.